Sandro Bruno

Novartis (Switzerland) — Switzerland

Medicine · Health Sciences

5h-index338citations15works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dermatology and Skin Diseases(6), Psoriasis: Treatment and Pathogenesis(4), Asthma and respiratory diseases(3), Allergic Rhinitis and Sensitization(3), BRCA gene mutations in cancer(2)

Publications15 total

Additional file 2 of Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Additional file 1 of Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Additional file 1 of Genetic liability to psoriasis predicts severe disease outcomes
Research Portal (King's College London)·2026Open Access
Additional file 2 of Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Genetic liability to psoriasis predicts severe disease outcomes
Figshare·2026Open Access
Genetic liability to psoriasis predicts severe disease outcomes
Genome Medicine·2025Open Access
Multi-omic triangulation identifies molecular candidates of atopic dermatitis severity
2025Open Access
Modelling atopic dermatitis in healthy human skin for the characterization of topical compounds
Experimental Dermatology·2024Open Access
IL-26 Potentiates Type 2 Skin Inflammation in the Presence of IL-1β
Journal of Investigative Dermatology·2024· 5 citedOpen Access
Design of a Supersoft Topical JAK Inhibitor, Which Is Effective in Human Skin but Rapidly Deactivated in Blood
Journal of Medicinal Chemistry·2023Open Access
Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in mice
European Journal of Pharmacology·2023· 7 cited
Discovery and Characterization of the Topical Soft JAK Inhibitor CEE321 for Atopic Dermatitis
Journal of Medicinal Chemistry·2023· 15 citedOpen Access
Author Correction: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
Nature·2021· 7 citedOpen Access
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
Nature·2021· 304 citedOpen Access

Frequent Co-authors

Ravi Ramessur(8), Katie Watts(8), David Baudry(7), Laura Huilaja(7), Manpreet K. Sagoo(7), Tanel Traks(7), Samuel Lessard(6), Mahmut Akyol(6), Laurent Thomas(6), J. Zierer(6), Anne Barton(6), John Bowes(6), Ben Brumpton(6), Vinod Chandran(6), Clément Chatelain(6), Emanuele de Rinaldis(6), James T. Elder(6), David Ellinghaus(6), John Foerster(6), Dafna D. Gladman(6)